Maurie Markman, MD
The term statistically significant
is almost certainly beautiful music to the ears of clinical investigators and pharma/biotech companies. This trial-related event likely means the opportunity to publish in a high-impact medical journal and, in the case of an industry-sponsored effort, may lead to regulatory approval or an increase in sales. And why challenge this scenario?
... to read the full story